Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $52,608 - $60,411
-2,032 Reduced 20.41%
7,925 $219,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $43,036 - $55,899
-1,647 Reduced 14.19%
9,957 $286,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $32,410 - $37,885
1,010 Added 9.53%
11,604 $384,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $23,839 - $27,581
-660 Reduced 5.86%
10,594 $388,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $90,636 - $117,995
-2,301 Reduced 16.98%
11,254 $459,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $565,921 - $738,747
13,555 New
13,555 $694,000
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $171,196 - $212,133
-3,742 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $154,619 - $229,197
3,742 New
3,742 $221,000
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $368,165 - $472,939
-9,380 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $336,835 - $381,578
9,380 New
9,380 $367,000
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $306,937 - $337,222
-8,185 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $423 - $482
11 Added 0.13%
8,185 $357,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $206 - $250
6 Added 0.07%
8,174 $360,000
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $74,633 - $79,567
2,263 Added 38.32%
8,168 $296,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $37,685 - $43,720
-1,181 Reduced 16.67%
5,905 $210,000
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $19,789 - $20,997
-595 Reduced 7.75%
7,086 $257,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $238,111 - $262,306
7,681
7,681 $274,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aureus Asset Management, LLC Portfolio

Follow Aureus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.